Liu, T.-W.; Chen, Y.-P.; Ho, C.-Y.; Chen, M.-J.; Wang, H.-Y.; Shih, S.-C.; Liou, T.-C.
Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study. Biomedicines 2023, 11, 1084.
https://doi.org/10.3390/biomedicines11041084
AMA Style
Liu T-W, Chen Y-P, Ho C-Y, Chen M-J, Wang H-Y, Shih S-C, Liou T-C.
Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study. Biomedicines. 2023; 11(4):1084.
https://doi.org/10.3390/biomedicines11041084
Chicago/Turabian Style
Liu, Ting-Wen, Yen-Po Chen, Cheng-Yu Ho, Ming-Jen Chen, Horng-Yuan Wang, Shou-Chuan Shih, and Tai-Cherng Liou.
2023. "Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study" Biomedicines 11, no. 4: 1084.
https://doi.org/10.3390/biomedicines11041084
APA Style
Liu, T.-W., Chen, Y.-P., Ho, C.-Y., Chen, M.-J., Wang, H.-Y., Shih, S.-C., & Liou, T.-C.
(2023). Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study. Biomedicines, 11(4), 1084.
https://doi.org/10.3390/biomedicines11041084
